172 related articles for article (PubMed ID: 15752921)
1. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.
Reaven GM
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):49-62. PubMed ID: 15752921
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance: why is it important to treat?].
Reaven GM
Diabetes Metab; 2001 Apr; 27(2 Pt 2):247-53. PubMed ID: 11452218
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.
Kim SP; Catalano KJ; Hsu IR; Chiu JD; Richey JM; Bergman RN
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1590-8. PubMed ID: 17264230
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Ruge T; Sukonina V; Kroupa O; Makoveichuk E; Lundgren M; Svensson MK; Olivecrona G; Eriksson JW
Metabolism; 2012 May; 61(5):652-60. PubMed ID: 22078753
[TBL] [Abstract][Full Text] [Related]
6. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
7. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
Iannello S; Milazzo P; Belfiore F
Obes Rev; 2007 May; 8(3):231-51. PubMed ID: 17444965
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
Abbasi F; Farin HM; Lamendola C; McGraw L; McLaughlin T; Reaven GM
Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
[TBL] [Abstract][Full Text] [Related]
9. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
10. Digitalis-like factor response to hyperinsulinemia in human pregnancy, a model of insulin resistance.
Seely EW; Carroll JA; Goodfriend TL; Tao QF; Graves W
J Hum Hypertens; 2002 Dec; 16(12):851-6. PubMed ID: 12522466
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
[TBL] [Abstract][Full Text] [Related]
12. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
[TBL] [Abstract][Full Text] [Related]
13. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
14. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
15. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism.
Girard J; Lafontan M
Diabetes Metab; 2008 Nov; 34(5):439-45. PubMed ID: 18562233
[TBL] [Abstract][Full Text] [Related]
16. The insulin resistance syndrome: definition and dietary approaches to treatment.
Reaven GM
Annu Rev Nutr; 2005; 25():391-406. PubMed ID: 16011472
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
[TBL] [Abstract][Full Text] [Related]
18. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
[TBL] [Abstract][Full Text] [Related]
19. [Conditioning of hyperglycemia and hyperinsulinemia in genetically obese mice through resistance to insulin].
Genes SG
Fiziol Zh; 1974; 20(2):265-72. PubMed ID: 4595869
[No Abstract] [Full Text] [Related]
20. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
